These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 21192319)
21. The crossmatch may still be the most clinically relevant histocompatibility test performed. Kerman R; Lappin J; Kahan B; Katz S; McKissick E; Hosek K; Acorda N; Wooley N; Hoover A; Miller K; Rodriguez L; Moore B; Melcher P; Biedermann B; Van Buren C Clin Transpl; 2007; ():227-9. PubMed ID: 18642454 [TBL] [Abstract][Full Text] [Related]
32. Donor-specific HLA class I and CREG antibodies in complement-dependent cytotoxicity-negative renal transplants. Kim Y; Yang CW; Moon IS; Kim M; Lim J; Park YJ; Han K; Oh EJ Ann Clin Lab Sci; 2010; 40(4):330-5. PubMed ID: 20947806 [TBL] [Abstract][Full Text] [Related]
33. Risk factors for Banff borderline acute rejection in protocol biopsies and effect on renal graft function. Espinoza EH; González-Parra C; Macías-Díaz DM; Uribe-Uribe NO; Alberú J; Morales-Buenrostro LE Transplant Proc; 2010; 42(6):2376-8. PubMed ID: 20692484 [TBL] [Abstract][Full Text] [Related]
34. Monitoring of donor sensitization in kidney transplant recipients by flow cytometric crossmatch. Cinti P; Bachetoni A; Baiano V; Pretagostini R; Poli L; Berloco P; Renna Molajoni E; Cortesini R Transplant Proc; 1993 Dec; 25(6):3265-6. PubMed ID: 8266536 [No Abstract] [Full Text] [Related]
36. Flow cytometry cross-match before kidney transplantation in relation to early postransplant rejection. Slavcev A; Ivasková E; Kalanin J; Lácha J; Vítko S; Krejcová E; Sajdlová H; Hána I Bone Marrow Transplant; 1998 Dec; 22 Suppl 4():S114-5. PubMed ID: 9916654 [TBL] [Abstract][Full Text] [Related]
37. Cytotoxic crossmatches in renal transplant patients by conventional cytotoxicity, immunomagnetic cell separation, and flow cytometry. Horsburgh T; Mistry N; Sidgwick A; Bell PR Transplant Proc; 1990 Aug; 22(4):1899. PubMed ID: 2389479 [No Abstract] [Full Text] [Related]
38. Early and late impact of a positive flow cytometry crossmatch on graft outcome in primary renal transplant. Abou El Fettouh H; Cook DJ; Flechner S; Goldfarb D; Gill I; Modlin C; Dennis V; Novick AC Transplant Proc; 2001 Sep; 33(6):2968-70. PubMed ID: 11543814 [No Abstract] [Full Text] [Related]
39. Improved graft survival in highly sensitized patients undergoing renal transplantation after the introduction of a clinically validated flow cytometry crossmatch. Limaye S; O'Kelly P; Harmon G; O'Neill D; Dorman AM; Walshe J; Donohoe J; Little D; Conlon PJ; Keogan MT Transplantation; 2009 Apr; 87(7):1052-6. PubMed ID: 19352127 [TBL] [Abstract][Full Text] [Related]
40. Flow cytometry PRA using lymphocyte pools from random donors. Won DI; Jung HD; Jung OJ; Huh S; Suh JS Cytometry B Clin Cytom; 2007 Jul; 72(4):256-64. PubMed ID: 17205570 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]